Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review.
- Published In:
- Journal of clinical medicine, 14(21) (2025)
- Database ID:
- RPEP-11109
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11109APA
Giorgio, Anna; Varani, Michela; Lauri, Chiara; Bentivoglio, Valeria; Nayak, Pallavi. (2025). Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review.. Journal of clinical medicine, 14(21). https://doi.org/10.3390/jcm14217811
MLA
Giorgio, Anna, et al. "Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review.." Journal of clinical medicine, 2025. https://doi.org/10.3390/jcm14217811
RethinkPeptides
RethinkPeptides Research Database. "Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Ag..." RPEP-11109. Retrieved from https://rethinkpeptides.com/research/giorgio-2025-radiolabeled-lhrh-and-fsh
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.